Plasma technology has recently made considerable progress in medicine. Medical plasma technology has ever been evolving since its first introduction. The first implementation of plasma technology dates back to the 1970s, when it was initially used as a surgical cutting device. Since then, medical doctors, scientists, and engineers have strived to identify the biological effect of plasma on cells, seeking its medical uses. As a result, plasma technology is being tested for its use for various indications ranging from decontamination to cancer treatment.
Sofia-based Mechan Europe supplies plasma technology surgical devices for application in the fields of ENT, Orthopedics, Urology, Spine, Gynecology, and Ophthalmology. The plasma technology that the company offers has incredible benefits as a surgical tool as it allows to separate molecules for ablation with very little damage to the surrounding tissues while working at a low temperature. This enables doctors and surgeons to work with greater precision than ever before and gives patients shorter recovery times.
Since 2012, Mechan Europe is a leading provider of plasma treatment systems. The company is closely involved in the research and development of plasma technology within the field of medicine and the manufacturing process of the plasma technology. "We strive to instil trust in our clients through the means of our exceptional customer service and quality of our products," states Lien Au, CEO of Mechan Europe. Starting with a small assortment of products, the firm has grown into a global leader in the market. Today, the company manufactures and distributes medical devices for performing surgical procedures in the medical fields of ENT, Spine, Orthopedic, Gynecology, and Urology. Currently, Mechan Europe serves numerous countries across North America, Europe, Asia, and Africa.
Low-Temperature Plasma Technology
Mechan Europe's plasma technology devices are able to create a stable plasma layer of only 50um thick around the active electrode through the conductive medium (mainly H2O and NaCl and air). While conventional electrosurgical devices use imprecise heat-driven processes to remove, cut tissue or for coagulation, Mechan Europe's plasma probe carries out cutting, coagulation, dissection, and hemostasis by creating high-density energy within a 100KHz electric field. Plasma at high-speed moving generates kinetic energy to break molecular bonds (40-70C), making the molecules separate from each other, and the tissue volume gets reduced. The thermal injury is controlled within 0.5mm, collateral damage to surrounding healthy tissues limited to the least. The low-temperature plasma can precisely control the temperature at 40-70C during the hemostasis process, which ensures the collagen molecule's spiral structure shrinks and maintains the vitality of the cells.
Plasma Gynaecology Surgical System PLA-700
Mechan Europe's Plasma Gynaecology Surgical System PLA-700 has a long list of advantages. The surgical process is performed at a controlled temperature of 40-70C. As the radio frequency is conducted into the saline solution to create the plasma sheath rather than into the tissues themselves, there is minimal heat damage with this system.
We strive to instil trust in our clients through the means of our exceptional customer service and quality of our products
Using unique temperature control technology, the system stays at the ideal temperature for a stable and effective output. With a radio frequency enabled plasma surgical system, radio frequency flows through an active electrode and return electrode. At the same time, a conductive saline solution generates a precisely focused plasma sheath around the electrodes. The massive charged particles within the plasma sheath create enough energy to break the tissue's organic molecular bonds, dissolving it into molecules and atoms at the relatively low temperature of 40-70C. This means that one can ablate tissue quickly and with minimal damage to the surrounding healthy cells. When radio frequency acts on the tissue (including blood), it creates a reaction that causes coagulation and hemostasis while preserving the mucosa and fibrous tissue and each cell's vitality. Patients experience a faster and more comfortable post-operative recovery with plasma ablation during surgery when compared to more traditional methods. The adjustable coagulation mode can improve hemostasis while giving surgeons a clear field of vision when operating.
PLA-700 continually monitors and automatically suspends its power output if the electrode contracts or is too close to the metal. Once the electrode is in the correct position, the power output will resume. With an intelligent control system, PLA-700 automatically identifies the electrodes, footswitch, and power supply. The state-of-the-art plasma gynaecology surgical system comes with various bipolar and multipolar electrode designs which are available for rapid resection, ablation, coagulation and hemostasis of soft tissues. PLA-700 has an integrated function – the versatile single-use electrode has an ABLATE mode for resection and ablation and a COAG mode for coagulation, hemostasis, irrigation and suction. Surgeons can simply switch between the two modes using a colour-coded footswitch.
The length, diameter, radian, energy level of the probes are designed as per the requirements of different locations and diseases. All functions are achieved at the same one handle and in the same output socket. Thus there is no need to change probes frequently during surgery. The host's sound size can be adjusted, distinguishing working audible call of ABLATION and PLACOAG to avoid stepping on the wrong foot pedal. The host machine can automatically identify the connection status of the handle and footswitch. It sets the default power level after connecting the footswitch and probe. The host machine can also automatically identify the probe type and dynamically detect the plasma intensity at the tip of the probe. Supplied with the functions and accessories for multipolar suction and cutting, Mechan Europe's plasma gynaecology surgical system can carry out Salpingectomy, Oophorectomy, and Myomectomy, among others.
What Lies Ahead?
Mechan Europe is working on expanding its business and product line further. The company is currently focusing on developing RF plasma technology products for applications within Dermatology, Ophthalmology, and Gynecology. Medical professionals worldwide choose Mechan Europe as their steady supplier for the technology needed for the innovative plasma treatment systems for ENT, Spinal operations, Orthopedics, Urology, and other surgical procedures. This only became possible due to the company's focus on providing the highest quality plasma ablation technology currently available, thus improving the surgical outcomes and giving the ever-increasing number of patients an experience that is as pleasant as possible.